Arkolith/Insider Trading/CNTA/Form 4

Hukkelhoven Mathias

DirectorCentessa Pharmaceuticals plc (CNTA) · full profile →Form 4 · filed Jun 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Disposed to issuer(D)96K——0
Jun 24, 2026Disposed to issuer(D)48K——0
Jun 24, 2026Disposed to issuer(D)48K——0
Jun 24, 2026Disposed to issuer(D)40K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000611) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML